News

Lynch syndrome awareness day

Lynch syndrome. Even though it is the most common hereditary cancer syndrome in the world, it is mostly unknown. Lynch syndrome prevalence is currently estimated at 1 in 279 globally[1], meaning that in Europe alone

... read more

Announcement – CSO Appointment

We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind

... read more

The 27 selected companies have started their path in the @xeuropeproject, and they are in for a treat 🍬

Read our article to learn more about the startups & scaleups embarking on this journey and to get up to date with what comes next! 🚀📖

👉https://www.xeurope.eu/post/meet-europe-s-top-deeptech-startups-driving-healthtech-innovation

Searching for innovative #deeptech startups and scaleups with solutions for your business? @xeuropeproject might just have what you are looking for!

Connect until 30 June: https://xeurope.eu/investors

”Only 24 #Lynchsyndrome carriers need to be treated with 600 mg/day aspirin to prevent one colorectal cancer”

There’s a NNT to remember.

@CaPP3 @Lynch_Fi @MattYurgelun @AndyChanMD @GabrielaMoslein @EHTG_Tweets @SoMe4GenRisk @ASCAP_QMUL @Lynchsyndromirl

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30973-9/fulltext

Load More...